Triple
T32226678
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | FOLFIRI regimen |
E823219
|
entity |
| Predicate | doseAdjustment |
P61679
|
FINISHED |
| Object | dose reduction may be required in patients with UGT1A1*28 polymorphism for irinotecan |
—
|
LITERAL FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: dose reduction may be required in patients with UGT1A1*28 polymorphism for irinotecan | Statement: [FOLFIRI regimen, doseAdjustment, dose reduction may be required in patients with UGT1A1*28 polymorphism for irinotecan]
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: doseAdjustment Context triple: [FOLFIRI regimen, doseAdjustment, dose reduction may be required in patients with UGT1A1*28 polymorphism for irinotecan]
-
A.
doseAdjustmentRequiredIn
chosen
Indicates that a change in the amount or frequency of a treatment or medication is necessary within a specified context, such as a condition, setting, or patient group.
-
B.
dosageAdded
Indicates that an additional amount of a substance or medication has been administered or incorporated into an existing dosage.
-
C.
doseRegimen
Indicates the specific schedule, frequency, and amount with which a dose of a substance or medication is to be administered.
-
D.
hasDosingRegimen
Indicates that an entity is associated with a specific dosing regimen, defining how and when a dose is to be administered.
-
E.
hasMaintenanceDose
Indicates that an entity is associated with a specific ongoing dose used to maintain a desired therapeutic effect after initial treatment.
- F. None of above.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69f3490b4f948190b99e4f999f5be25f |
completed | April 30, 2026, 12:20 p.m. |
| NER | Named-entity recognition | batch_69f6bbcbd31c8190a482a5fd5040410d |
completed | May 3, 2026, 3:06 a.m. |
| PD | Predicate disambiguation | batch_69f6b632cf788190a3d0c08cd026b84b |
completed | May 3, 2026, 2:42 a.m. |
Created at: May 1, 2026, 12:38 a.m.